BioCryst Pharmaceuticals

Ebit Changement Date
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Gilead Sciences USD 2.15B 475M 2023-12
GlaxoSmithKline GBP 2.59B 602M 2023-09
Incyte USD 205.23M 10.1M 2023-12
Intra Cellular Therapies USD -34097000 4.38M 2023-12
Ionis Pharmaceuticals USD -6123000 137.14M 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Regeneron Pharmaceuticals USD 1B 208.1M 2023-12
Roche Holding CHF 10.6B 2.12B 2023-06
Sarepta Therapeutics USD -20842000 112.68M 2023-09
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



BioCryst Pharmaceuticals - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.